CytomX Therapeutics, Inc. (CTMX)
5.47
+0.06
(+1.11%)
USD |
NASDAQ |
Feb 19, 16:00
5.48
+0.01
(+0.18%)
After-Hours: 20:00
CytomX Therapeutics Price : 5.47 for Feb. 19, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| REGENXBIO, Inc. | 8.41 |
| ACADIA Pharmaceuticals, Inc. | 24.33 |
| Alnylam Pharmaceuticals, Inc. | 339.37 |
| Savara, Inc. | 5.72 |
| BioMarin Pharmaceutical, Inc. | 63.42 |
Price Related Metrics
| PE Ratio | 13.08 |
| PS Ratio | 5.552 |
| PEG Ratio | 0.0892 |
| Price to Book Value | 8.630 |
| Earnings Yield | 7.65% |
| Market Cap | 926.81M |
| PEGY Ratio | 0.0892 |
| Operating PE Ratio | 27.26 |
| Normalized PE Ratio | 13.10 |